Shenzhen Geno-immune Medical Institute
Clinical trials sponsored by Shenzhen Geno-immune Medical Institute, explained in plain language.
-
Immune cells engineered to fight ovarian cancer enter human testing
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests a new treatment for ovarian cancer using specially engineered immune cells (OC-EIEs) designed to recognize and attack cancer cells. About 20 women with advanced ovarian cancer will receive the therapy to see if it is safe and can shrink tumors. The go…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Engineered t cells take on deadly brain tumors in new trial
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests a new treatment for glioblastoma, an aggressive brain cancer. It uses a patient's own immune cells that are genetically modified to better recognize and attack the tumor. The study enrolls 30 people with recurrent glioblastoma and aims to check the tr…
Phase: PHASE1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC